期刊文献+

中心性浆液性脉络膜视网膜病变的光动力治疗

原文传递
导出
摘要 中心性浆液性脉络膜视网膜病变(CSC),是一种好发于中青年男性的自限性疾病,但由于易反复发作,且对中心视力的严重损害往往是不可逆的,所以寻求安全有效的治疗方法一直是研究的热点。近几年来,光动力疗法(PDT)在不同发展阶段的CSC应用备受关注。现对PDT治疗CSC的进展作一综述。
作者 曹亚娜 张明
出处 《华西医学》 CAS 2013年第8期1308-1310,共3页 West China Medical Journal
  • 相关文献

参考文献21

  • 1Maria W Inger CM,Pascal WH,et al.Central serous chorioretinopathy[J].Acta Ophthalmol,2008,86(2):126-145. 被引量:1
  • 2赵明威.努力探索发病机制,进一步提升治疗水平:中心性浆液性脉络膜视网膜病变研究的现实与挑战[J].中华眼底病杂志,2011,27(4):305-308. 被引量:30
  • 3Gass JD,Little H.Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy[J].Ophthalmology,1995,102(5):737-747. 被引量:1
  • 4TAP Study Group.Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin:one-year results of 2 randomized clinical trials-TAP report.Treatment of age-related macular degeneration with photodynamic therapy(TAP) study group[J].Arch Ophthalmol,1999,117(10):1329-1345. 被引量:1
  • 5Allison BA,Pritchard PH,Levy JG.Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative[J].Br J Cancer,1994,69(5):833-839. 被引量:1
  • 6Engbrecht BW,Menon C,Kachur AV,et al.Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model[J].Cancer Res,1999,59(17):4334-4342. 被引量:1
  • 7Tsujikawa A,Ojima Y,Yamashiro K,et al.Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography[J].Retina,2010,30(5):801-809. 被引量:1
  • 8刘晓玲,林冰,瞿佳.中心性浆液性脉络膜视网膜病变的吲哚青绿和荧光素眼底血管造影[J].中华眼底病杂志,2000,16(1):14-16. 被引量:30
  • 9Lim JI,Flower RW.Indocyanine green angiography[J].Int Ophthalmol Clin,1995,35(4):59-70. 被引量:1
  • 10陆方,严密.中国眼底病论坛暨老年性黄斑变性暨糖尿病视网膜病专题研讨会论文集[G].上海,2008.中华医学会眼科学分会,北京:2008. 被引量:1

二级参考文献27

  • 1毕燕龙,荣翱,李锦文.微脉冲激光治疗中心性浆液性脉络膜视网膜病变的临床疗效[J].中华眼底病杂志,2007,23(1):45-47. 被引量:8
  • 2Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium.Ⅱ. Idiopathic central serous choroidopathy. Am J Ophthalmol,1967,63:587- 615. 被引量:1
  • 3Jumper JM. Central serous chorioretinopathy. Br J Ophthalmol, 2003,87:663. 被引量:1
  • 4Baran NV, Gurlu VP, Esgin H. I.ong term macular function in eyes with central serous chorioretinopathy. Clin Experiment Ophthalmol, 2005,33 : 369-372. 被引量:1
  • 5Yap EY, Robertson DM. The long term outcome of central serous chorioretinopathy. Arch Ophthalmol, 1996,114 : 689-692. 被引量:1
  • 6Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol, 2008,86 : 126-145. 被引量:1
  • 7Gilbert CM, Owens SL, Smith PD, et al. I.ong-term follow up of central serous chorioretinopathy. Br J Ophthalmol, 1984,68: 815- 820. 被引量:1
  • 8Castro-Correia J, Coutinho MF, Rosas V, et al. Long-term follow-up of central serous retinopathy in 150 patients. Doe Ophthalmol, 1992,81 : 379- 386. 被引量:1
  • 9Brancato R, Scialdone A, Peee A, et al. Eight-year follow up of central serous chorioretinopathy with and without laser treatment. Grades Arch Clin Exp Ophthalmol,1987,226:166- 168. 被引量:1
  • 10Otsuka S, Ohba N, Nakao K. A long-term follow-up study of severe variant of central serous ehorioretinopathy. Retina,2002, 22:25-32. 被引量:1

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部